vs
Side-by-side financial comparison of Seaport Entertainment Group Inc. (SEG) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
Seaport Entertainment Group Inc. is the larger business by last-quarter revenue ($29.5M vs $28.1M, roughly 1.0× ARS Pharmaceuticals, Inc.). Seaport Entertainment Group Inc. runs the higher net margin — -125.0% vs -147.1%, a 22.1% gap on every dollar of revenue.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
SEG vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $29.5M | $28.1M |
| Net Profit | $-36.9M | $-41.3M |
| Gross Margin | — | — |
| Operating Margin | -120.5% | -147.6% |
| Net Margin | -125.0% | -147.1% |
| Revenue YoY | — | -67.6% |
| Net Profit YoY | — | -182.8% |
| EPS (diluted) | $-2.90 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $29.5M | $28.1M | ||
| Q3 25 | $45.0M | $32.5M | ||
| Q2 25 | $39.8M | $15.7M | ||
| Q1 25 | $16.1M | $8.0M | ||
| Q4 24 | — | $86.6M | ||
| Q3 24 | $39.4M | $2.1M | ||
| Q2 24 | $33.7M | $500.0K | ||
| Q1 24 | — | $0 |
| Q4 25 | $-36.9M | $-41.3M | ||
| Q3 25 | $-33.2M | $-51.2M | ||
| Q2 25 | $-14.8M | $-44.9M | ||
| Q1 25 | $-31.9M | $-33.9M | ||
| Q4 24 | — | $49.9M | ||
| Q3 24 | $-32.5M | $-19.1M | ||
| Q2 24 | $-35.0M | $-12.5M | ||
| Q1 24 | — | $-10.3M |
| Q4 25 | -120.5% | -147.6% | ||
| Q3 25 | -75.2% | -163.7% | ||
| Q2 25 | -40.2% | -302.9% | ||
| Q1 25 | -203.5% | -466.3% | ||
| Q4 24 | — | 54.5% | ||
| Q3 24 | -51.0% | -1051.6% | ||
| Q2 24 | -75.3% | -3068.0% | ||
| Q1 24 | — | — |
| Q4 25 | -125.0% | -147.1% | ||
| Q3 25 | -73.7% | -157.4% | ||
| Q2 25 | -37.1% | -285.6% | ||
| Q1 25 | -198.4% | -425.7% | ||
| Q4 24 | — | 57.7% | ||
| Q3 24 | -82.5% | -925.0% | ||
| Q2 24 | -103.9% | -2503.2% | ||
| Q1 24 | — | — |
| Q4 25 | $-2.90 | $-0.41 | ||
| Q3 25 | $-2.61 | $-0.52 | ||
| Q2 25 | $-1.16 | $-0.46 | ||
| Q1 25 | $-2.51 | $-0.35 | ||
| Q4 24 | — | $0.52 | ||
| Q3 24 | $-5.89 | $-0.20 | ||
| Q2 24 | $-6.34 | $-0.13 | ||
| Q1 24 | — | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $77.8M | $245.0M |
| Total DebtLower is stronger | $38.3M | $96.4M |
| Stockholders' EquityBook value | $456.5M | $114.3M |
| Total Assets | $650.1M | $327.7M |
| Debt / EquityLower = less leverage | 0.08× | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $77.8M | $245.0M | ||
| Q3 25 | $106.2M | $288.2M | ||
| Q2 25 | $123.3M | $240.1M | ||
| Q1 25 | $129.9M | $275.7M | ||
| Q4 24 | — | $314.0M | ||
| Q3 24 | $23.7M | $204.6M | ||
| Q2 24 | $3.3M | $218.7M | ||
| Q1 24 | — | $223.6M |
| Q4 25 | $38.3M | $96.4M | ||
| Q3 25 | $39.3M | $96.2M | ||
| Q2 25 | $100.6M | — | ||
| Q1 25 | $101.6M | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $103.3M | — | ||
| Q2 24 | $157.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $456.5M | $114.3M | ||
| Q3 25 | $485.8M | $147.7M | ||
| Q2 25 | $517.9M | $192.3M | ||
| Q1 25 | $531.2M | $229.0M | ||
| Q4 24 | — | $256.8M | ||
| Q3 24 | $433.8M | $201.0M | ||
| Q2 24 | $380.7M | $215.2M | ||
| Q1 24 | — | $223.9M |
| Q4 25 | $650.1M | $327.7M | ||
| Q3 25 | $699.1M | $372.8M | ||
| Q2 25 | $717.2M | $313.5M | ||
| Q1 25 | $718.4M | $327.3M | ||
| Q4 24 | — | $351.2M | ||
| Q3 24 | $622.8M | $217.6M | ||
| Q2 24 | $610.1M | $222.0M | ||
| Q1 24 | — | $227.6M |
| Q4 25 | 0.08× | 0.84× | ||
| Q3 25 | 0.08× | 0.65× | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.19× | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 0.24× | — | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-23.1M | $-43.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-23.1M | $-43.5M | ||
| Q3 25 | $-5.3M | $-47.0M | ||
| Q2 25 | $-754.0K | $-39.6M | ||
| Q1 25 | $-20.5M | $-40.7M | ||
| Q4 24 | — | $42.0M | ||
| Q3 24 | $-8.8M | $-14.5M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $-6.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-47.2M | ||
| Q2 25 | — | $-39.6M | ||
| Q1 25 | — | $-40.8M | ||
| Q4 24 | — | $41.7M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $-6.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | -145.4% | ||
| Q2 25 | — | -252.2% | ||
| Q1 25 | — | -512.1% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | — | -706.3% | ||
| Q2 24 | — | -1463.4% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SEG
| Sponsorships Events And Entertainment | $12.5M | 43% |
| Hospitality | $12.2M | 41% |
| Rental | $4.1M | 14% |
| Other | $631.0K | 2% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
